Payment overview · 2025
General Payments
$159.97
3 reported records · 3 companies
Healthcare provider profile · identity verified
Heather Gaugler, APRN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · WICHITA, KS · NPI 1306254461
Verified facts
What the public records show
CMS Open Payments records show Heather Gaugler, APRN received $159.97 in general payments during 2025 across 3 reported records.
Dexcom, Inc. accounted for 77.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $124.10 | 77.6% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $18.14 | 11.3% | 1 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $17.73 | 11.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $159.97 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| DEXCOM G7 GSS (161) Normalized: dexcom g7 gss 161 |
Medical Supply | Dexcom, Inc. | $124.10 | 1 | 2025 |
Source payment records
|
|||||
| DEXCOM STELO GLUCOSE BIOSENSOR Normalized: dexcom stelo glucose biosensor |
Not specified | Dexcom, Inc. | $124.10 | 1 | 2025 |
Source payment records
|
|||||
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $18.14 | 1 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $17.73 | 1 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $17.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 17 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 886 | 113 |
| Atorvastatin Calcium | Atorvastatin Calcium | 771 | 110 |
| Potassium Chloride | Potassium Chloride | 682 | 110 |
| Amlodipine Besylate | Amlodipine Besylate | 596 | 82 |
| Donepezil Hcl | Donepezil Hcl | 560 | 85 |
| Omeprazole | Omeprazole | 468 | 71 |
| Pantoprazole Sodium | Pantoprazole Sodium | 429 | 60 |
| Gabapentin | Gabapentin | 428 | 60 |
| Mirtazapine | Mirtazapine | 413 | 67 |
| Furosemide | Furosemide | 403 | 64 |
| Sertraline Hcl | Sertraline Hcl | 374 | 43 |
| Eliquis | Apixaban | 373 | 49 |
| Quetiapine Fumarate | Quetiapine Fumarate | 371 | 74 |
| Memantine Hcl | Memantine Hcl | 364 | 53 |
| Lisinopril | Lisinopril | 336 | 51 |
| Metoprolol Tartrate | Metoprolol Tartrate | 327 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 290 | 44 |
| Trazodone Hcl | Trazodone Hcl | 268 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 267 | 40 |
| Tramadol Hcl | Tramadol Hcl | 260 | 58 |
| Lorazepam | Lorazepam | 242 | 73 |
| Losartan Potassium | Losartan Potassium | 226 | 40 |
| Famotidine | Famotidine | 220 | 31 |
| Allopurinol | Allopurinol | 211 | 28 |
| Divalproex Sodium | Divalproex Sodium | 210 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 198 | 26 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 194 | 43 |
| Metoprolol Succinate | Metoprolol Succinate | 188 | 29 |
| Bumetanide | Bumetanide | 186 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 178 | 26 |
| Levetiracetam | Levetiracetam | 175 | 20 |
| Warfarin Sodium | Warfarin Sodium | 160 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 154 | 26 |
| Simvastatin | Simvastatin | 151 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 149 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 147 | 28 |
| Meloxicam | Meloxicam | 147 | 17 |
| Metformin Hcl | Metformin Hcl | 143 | 20 |
| Myrbetriq | Mirabegron | 133 | 15 |
| Carvedilol | Carvedilol | 127 | 23 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 120 | 19 |
| Cephalexin | Cephalexin | 119 | 82 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 116 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 113 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 105 | 12 |
| Nystatin | Nystatin | 100 | 35 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 99 | 24 |
| Latanoprost | Latanoprost | 94 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 94 | 69 |
| Propranolol Hcl | Propranolol Hcl | 93 | suppressed |
| Fluconazole | Fluconazole | 89 | 41 |
| Risperidone | Risperidone | 89 | 19 |
| Pregabalin | Pregabalin | 84 | suppressed |
| Haloperidol | Haloperidol | 83 | 14 |
| Ibuprofen | Ibuprofen | 82 | 29 |
| Hydrochlorothiazide | Hydrochlorothiazide | 80 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 78 | 17 |
| Prednisone | Prednisone | 72 | 34 |
| Metformin Hcl Er | Metformin Hcl | 71 | suppressed |
| Olanzapine | Olanzapine | 70 | 13 |
| Alprazolam | Alprazolam | 68 | 20 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 67 | suppressed |
| Primidone | Primidone | 67 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 65 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 64 | suppressed |
| Januvia | Sitagliptin Phosphate | 61 | suppressed |
| Baclofen | Baclofen | 59 | 11 |
| Finasteride | Finasteride | 58 | 11 |
| Midodrine Hcl | Midodrine Hcl | 58 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 58 | 34 |
| Celecoxib | Celecoxib | 57 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 55 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 53 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 52 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 52 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 51 | suppressed |
| Spironolactone | Spironolactone | 50 | suppressed |
| Digoxin | Digoxin | 49 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 21 |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 47 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 47 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 47 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 46 | 30 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 45 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 44 | suppressed |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 42 | 32 |
| Tizanidine Hcl | Tizanidine Hcl | 41 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 40 | 39 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Azithromycin | Azithromycin | 39 | 21 |
| Alendronate Sodium | Alendronate Sodium | 38 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 36 | suppressed |
| Loperamide | Loperamide Hcl | 36 | 13 |
| Atenolol | Atenolol | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 25 |
| Naltrexone Hcl | Naltrexone Hcl | 35 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 34 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Lovastatin | Lovastatin | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 32 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 32 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 31 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 31 | suppressed |
| Xarelto | Rivaroxaban | 31 | suppressed |
| Irbesartan | Irbesartan | 30 | suppressed |
| Estradiol | Estradiol | 28 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 27 | 15 |
| Metolazone | Metolazone | 27 | 13 |
| Nystop | Nystatin | 26 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 25 | 25 |
| Clindamycin Hcl | Clindamycin Hcl | 25 | 12 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 25 | 19 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Paliperidone Er | Paliperidone | 23 | suppressed |
| Ezetimibe | Ezetimibe | 22 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 22 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 22 | suppressed |
| Carbamazepine | Carbamazepine | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Jardiance | Empagliflozin | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 21 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Levemir Flexpen | Insulin Detemir | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 19 | suppressed |
| Timolol Maleate | Timolol Maleate | 19 | suppressed |
| Calcitriol | Calcitriol | 18 | suppressed |
| Glimepiride | Glimepiride | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | 13 |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 16 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 12 |
| Cefdinir | Cefdinir | 15 | 14 |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Vraylar | Cariprazine Hcl | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Entacapone | Entacapone | 14 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 14 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 14 | suppressed |
| Rexulti | Brexpiprazole | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Cymbalta | Duloxetine Hcl | 12 | suppressed |
| Ethambutol Hcl | Ethambutol Hcl | 12 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 12 | suppressed |
| Nitroglycerin | Nitroglycerin | 12 | suppressed |
| Np Thyroid | Thyroid,pork | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 12 | suppressed |
| Admelog Solostar | Insulin Lispro | 11 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 11 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Constulose | Lactulose | 11 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Donepezil Hcl Odt | Donepezil Hcl | 11 | suppressed |
| Famciclovir | Famciclovir | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Methylprednisolone Acetate | Methylprednisolone Acetate | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Rytary | Carbidopa/Levodopa | 11 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $159.97 · 3 records | Dexcom, Inc. | DEXCOM G7 GSS (161), DEXCOM STELO GLUCOSE BIOSENSOR, Flexitouch Plus, Nimbl, TRELEGY ELLIPTA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error